Acquisitions - Narrative (Details) $ in Thousands, € in Millions		1 Months Ended				9 Months Ended	12 Months Ended
	Jul. 31, 2025 USD ($)	Jul. 31, 2025 USD ($)	Jul. 31, 2025 EUR (€)	Feb. 28, 2025 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($)	Dec. 31, 2024 USD ($)
Business Combination [Line Items]
Goodwill, acquired during period						$ 146,984
Property, equipment, and software, net						$ 267,438	$ 82,083
Useful life					10 years
C S Bio Co.
Business Combination [Line Items]
Consideration transferred				$ 39,100
Payments for asset acquisitions				32,700
Property, equipment, and software, net				41,200
Acquisition cost				2,100
C S Bio Co. | Maximum
Business Combination [Line Items]
Contingent consideration transferred				6,400
Earn out consideration transferred				32,700
Zava Global GmbH
Business Combination [Line Items]
Business combination, consideration		$ 258,000	€ 219.2
Cash consideration		167,300	142.2
Consideration subject to earn-out conditions		90,700	77.0
Goodwill, acquired during period	$ 142,000
Business combination, acquisition related costs		7,900
Zava Global GmbH | Maximum
Business Combination [Line Items]
Consideration subject to earn-out conditions		$ 117,700	€ 100.0
Sigmund NJ, LLC, Trybe Labs
Business Combination [Line Items]
Cash consideration				5,100
Goodwill, acquired during period				$ 5,000
Seaview Enterprises LLC, MedisourceRx
Business Combination [Line Items]
Business combination, consideration					$ 31,000
Goodwill, acquired during period							$ 1,800
Business combination, acquisition related costs					$ 1,400